Hepatitis C treatments: Australia urged to subsidise 'revolutionary' new drugs
Experts have called for new oral therapies to treat hepatitis C to be subsidised in Australia, starting with the most vulnerable patients, as reported in ABC News Australia.
Professor Geoff McCaughan, said the new «revolutionary» treatment, which is being rolled out in the US and Europe, can lead to «about 95 percent cure rates with one or two tablets a day, essentially without any side effect.»
«If you walk in the door with chronic hepatitis C infection, academically and medically you should be able to get these medications at some stage within the next one to three to five years," he added.
However, he noted that «the problem at the moment is the cost of these drugs in Europe and the United States is extraordinarily high — you know, $90,000 to $100,000 or even more.»